03:52 PM EST - Valeant Pharmaceuticals International, Inc. : announced that its wholly-owned subsidiary, Valeant Pharmaceuticals International, will redeem $450-million aggregate principal amount of its outstanding 6.50% Senior Notes due 2016 CUSIP Nos. 91911XAR5, U9098VAH5 and has mailed an irrevocable notice of redemption for the Notes. Valeant Pharmaceuticals International intends to mail an irrevocable notice of redemption for the remaining $465.5-million aggregate principal amount of the Notes on or about December 2. Valeant Pharmaceuticals International, Inc.
shares T.VRX are trading down $0.43 at $111.43.
